Cargando…

Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells

BACKGROUND: Relapsed/refractory B-precursor acute lymphoblastic leukemia (BCP-ALL) remains a major therapeutic challenge in pediatric hematology. Chimeric antigen receptor (CAR) T cells targeting CD19 have shown remarkable initial response rates in BCP-ALL patients, while long-term leukemia control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willier, Semjon, Raedler, Johannes, Blaeschke, Franziska, Stenger, Dana, Pazos Escudero, Montserrat, Jurgeleit, Florian, Grünewald, Thomas G P, Binder, Vera, Schmid, Irene, Albert, Michael H, Wolf, Armin, Feuchtinger, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497522/ https://www.ncbi.nlm.nih.gov/pubmed/32938628 http://dx.doi.org/10.1136/jitc-2020-001052

Ejemplares similares

Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function
por: Blaeschke, Franziska, et al.
Publicado: (2022)

Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
por: Kaeuferle, Theresa, et al.
Publicado: (2019)

Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a non-interventional observation study
por: Willier, Semjon, et al.
Publicado: (2019)

Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
por: Blaeschke, Franziska, et al.
Publicado: (2021)

Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells
por: Kaeuferle, Theresa, et al.
Publicado: (2022)

Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2020)

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
por: Cordes, Nicole, et al.
Publicado: (2021)

Intraocular Pressure and Associations in Children. The Gobi Desert Children Eye Study
por: Yang, Da Yong, et al.
Publicado: (2014)

Unpredictability of escape trajectory explains predator evasion ability and microhabitat preference of desert rodents
por: Moore, Talia Y., et al.
Publicado: (2017)

Generation of full-length circular RNA libraries for Oxford Nanopore long-read sequencing
por: Fuchs, Steffen, et al.
Publicado: (2022)

CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2020)

Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
por: Sauerer, Tatjana, et al.
Publicado: (2023)

Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
por: Jacoby, Elad
Publicado: (2019)

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
por: An, Lihong, et al.
Publicado: (2022)

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL
por: Jeyakumar, Nikeshan, et al.
Publicado: (2022)

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
por: Su, Christopher T., et al.
Publicado: (2021)

Comprehensive comparison of three different animal models for systemic inflammation
por: Seemann, Semjon, et al.
Publicado: (2017)

T-cell responses against CD19(+) pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts
por: Feucht, Judith, et al.
Publicado: (2016)

Desert Dermatoses (Thar Desert, India)
por: Chatterjee, Col Manas
Publicado: (2017)

Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape
por: Xie, Danni, et al.
Publicado: (2023)

CTCF-mediated insulation and chromatin environment modulate Car5b escape from X inactivation
por: Fang, He, et al.
Publicado: (2023)

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
por: Bader, Peter, et al.
Publicado: (2023)

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
por: Meier, Jeremy A., et al.
Publicado: (2022)

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
por: Rentsch, Vera, et al.
Publicado: (2022)

Anti‑BCMA CAR‑T cell immunotherapy for relapsed or refractory multiple myeloma
por: Zhang, Xiaohui, et al.
Publicado: (2023)

Déserts
por: Varése, Edgard, 1883-1965
Publicado: (1959)

Magnetron Sputtering as a Fabrication Method for a Biodegradable Fe32Mn Alloy
por: Jurgeleit, Till, et al.
Publicado: (2017)

Mechanical Properties and In Vitro Degradation of Sputtered Biodegradable Fe-Au Foils
por: Jurgeleit, Till, et al.
Publicado: (2016)

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
por: Pagliuca, Simona, et al.
Publicado: (2023)

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
por: Pagliuca, Simona, et al.
Publicado: (2023)

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
por: Wang, Zhenzhen, et al.
Publicado: (2023)

Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy
por: Zhang, Zhen, et al.
Publicado: (2020)

Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia
por: Liao, Wenjuan, et al.
Publicado: (2021)

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
por: Wachsmann, Tassilo L. A., et al.
Publicado: (2023)

Désert ; Dormeuses
por: López Reyes, Cutberto
Publicado: (2005)

CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
por: Vu, Khoan, et al.
Publicado: (2022)

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
por: Lamble, Adam J., et al.
Publicado: (2022)

CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
por: Cavo, Michele
Publicado: (2023)

A study of Desert Dermatoses in the Thar Desert Region
por: Chatterjee, Manas, et al.
Publicado: (2015)

Desert soilization: The concept and practice of making deserts bloom
por: Yi, Zhijian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5b1itcp4t7kghfj4pieepl1oh5